09:33 EST NovoCure trading halted, volatility trading pause
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCR:
- NVCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- NovoCure’s Lung Cancer Therapy Application Accepted by FDA
- FDA accepts Novocure PMA application for TTFields therapy in NSCLC
- Novocure enrolls final patient in TRIDENT clinical trial
- Novocure sees FY23 revenue $509.3M, consensus $505.05M
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue